Phase 1 Single Dose Escalation Study of CTB-001
NCT01647893
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
CTB-001
Sponsor
HLB Pharmaceutical Co., Ltd.